free hit counters
French Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023

Read more ››
By: GlobeNewswire - 24 Jul 2023
Related companies:  Eurobio Scientific

AvenCell Therapeutics Announces EMA Approval of Clinical Trial Application (CTA) for AVC-201, a Novel Allogeneic CD123-Directed Switchable CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and other CD123 H

Read more ››
By: PR Newswire Association LLC. - 24 Jul 2023

AvenCell Therapeutics Announces EMA Approval of Clinical Trial Application (CTA) for AVC-201, a Novel Allogeneic CD123-Directed Switchable CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and other CD123 H

Read more ››
By: PR Newswire Association LLC. - 24 Jul 2023

Fractus expands into healthcare with wireless implantable device technology

Read more ››
By: PR Newswire Association LLC. - 24 Jul 2023

Ipsen announces a simplification of the concert of its principal shareholders representing 56.62% of the share capital and 72.36% of voting rights - effective from December 19, 2023

Read more ››
By: GlobeNewswire - 24 Jul 2023
Related companies:  Ipsen SA

Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome  

Read more ››
By: GlobeNewswire - 21 Jul 2023
Related companies:  Ipsen SA

Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome  

Read more ››
By: GlobeNewswire - 21 Jul 2023
Related companies:  Ipsen SA

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

Read more ››
By: PR Newswire Association LLC. - 21 Jul 2023

Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine Results From European Phase III Study (PYTHON Trial)

Read more ››
By: GlobeNewswire - 21 Jul 2023
Related companies:  Curium Pharma

Voting Rights and Shares Capital of the Company

Read more ››
By: GlobeNewswire - 20 Jul 2023
Related companies:  Nanobiotix SA | Nanoco Technologies Ltd.  

Advent Therapeutics Receives FDA Rare Pediatric Disease Designation for Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants

Read more ››
By: GlobeNewswire - 20 Jul 2023

Guerbet: First-half 2023 revenue

Read more ››
By: GlobeNewswire - 20 Jul 2023
Related companies:  Guerbet SA

PRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING TO SELFCARE PRODUCTS

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023

Promontory Therapeutics Expands Phase 2 Trial of PT-112 in Metastatic Castrate-Resistant Prostate Cancer to France

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023

Rarecells, Inc. announces a breakthrough publication on Circulating Giant Cancer Cells detected in patients with MDS

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023
Related companies:  Rarecells Diagnostics SAS

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023
Related companies:  UroMems

Crossject signs new licensing agreement on ZENEO® Midazolam epilepsy rescue therapy with AFT Pharmaceuticals for Australia & New Zealand

Read more ››
By: GlobeNewswire - 20 Jul 2023
Related companies:  Crossject

Sathgen Therapeutics announces dosing of the first patient cohort with MSP008-22, a novel anti-cancer drug

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023

AOU Parma chooses Deenova's RFID solution for medical device traceability and its proven benefits

Read more ››
By: PR Newswire Association LLC. - 20 Jul 2023

SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023

Read more ››
By: GlobeNewswire - 19 Jul 2023
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of France?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • September 2023
    • Diegem: Pharma-Biotech Product & Company Valuation with Dr. P Frei
    • Barcelona: BioSpain 2023
  • October 2023
    • New York City: BioFuture
See Events »
Add an Event »

Latest company news

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older
22 Sep 2023 (PR Newswire Association LLC.)

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes
22 Sep 2023 (GlobeNewswire)

Wandercraft bringt Atalante X, das erste selbststabilisierende Geh-Exoskelett der Welt, in Deutschland auf den Markt
22 Sep 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The French Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com